Your browser doesn't support javascript.
loading
Evaluation of different volumetric-modulated arc therapy for the large planning target volume in T3 lung cancer / 中国基层医药
Chinese Journal of Primary Medicine and Pharmacy ; (12): 1665-1669, 2019.
Artigo em Chinês | WPRIM | ID: wpr-753667
ABSTRACT
Objective To investigate the feasibility and dosimetric characteristics of using dual - arc volumetric modulated arc therapy and multiple partial-arc VMAT for T3 lung cancer.Methods From June 2016 to May 2018,thirteen lung cancer patients with large planning target volume were replanned with dual full arcs VMAT (F-VMAT) and six partial-arc s VMAT( P-VMAT) on RayStation v4.5 RayArc function.PTV volume median was 550.9cm3(ranged 402.2-834.8cm3 ) and to a prescribed dose of 60 Gy in 30 fractions.Equivalent target coverage was required for all plans,and clinical goals were evaluated using various dose-volume metrics.These included PTV dose conformity,mean lung/heart dose,lung V5 ,V10 ,V20 ,V30 ,heart V30 and V40 ,and Dmax of spinal canal.The total monitor units ( MUs) were also examined. Results All VMAT plans satisfied the treatment criteria. F - VMAT achieved better homogeneity index ( HI) and MUs than P -VMRT( t = -3.904,P =0.002),and the conformal number(CN) of tumor volumes was likely clinically indistinguishable.However,F-VMAT significantly reduced lung V5 ,V10 and mean lung dose[V5(51.31 ± 5.36)% vs.(43.44 ± 5.28)%,t=6.908,P=0.00;V10(38.34 ± 3.26)% vs.(34.05 ± 3.74)%,t=4.632,P=0.001;Dmean(1 449 ± 117.19)cGy vs.(1 375.38 ± 148.98)cGy, t=4.93, P =0.00 ], and heart dosimetric parameters were also observed in favor of P - VMRT [ V30 (20.6 ± 10.4)% vs.(16.4 ± 8.9)%,t =3.822,P =0.02;V40(14.6 ± 7.5)% vs.(11.88 ± 7.1)%,t =3.096,P =0.009;Dmean(1 442.9 ± 651.2)cGy vs.(1 263.5 ± 605.6)cGy,t=3.986,P=0.02],and there were no statisti-cally significant differences in lung V20,V30 and spinal cord Dmax between the two groups(all P>0.05).Conclusion VMAT is an effective treatment for stage T3 lung cancer patients. The primary advantage of P - VMAT was the reduction in low dose area and decreased risk of symptomatic radioactive lung injury.It may be a priority for pulmonary malignancy patients with the large planning target volume.

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Idioma: Chinês Revista: Chinese Journal of Primary Medicine and Pharmacy Ano de publicação: 2019 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Idioma: Chinês Revista: Chinese Journal of Primary Medicine and Pharmacy Ano de publicação: 2019 Tipo de documento: Artigo